SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MCAR
MCAR 0.0650-36.3%Jan 31 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: zgoodman who wrote (222)4/21/1998 5:12:00 PM
From: Andrew Q. Viet   of 467
 
Let him short the stock. He doesn't really know the company. He got financially slaughtered with ktel and acrt( shorted ktel at 8-9 and acrt at 11) and soon he's going to be slaughtered by mcar.

MCAR program of UI treatments are backed by well-known urologists in the country.
Dr.Wein,In addition to being Chairman of MedCare's Medical Advisory Board also serves on the Medical Board of Pharmacia & Upjohn, Inc. , and is Professor and Chair, Division of Urology, at the University of Pennsylvania.
MCAR treatment programs are paid for by most insurance companies.
there are million of Americans who suffer from Urinary Incontinence and MCAR has one of the best treatment programs. It 's a big market and MCAr will capitalize on the potential of that market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext